Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
2023 Shareholders General Meeting | |||||
By: GlobeNewswire - 26 Mar 2024 | Back to overview list |
||||
Press release Ecully, March 26, 2024 – 8.00 p.m.
Minutes of the General Meeting of March 25, 2024 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on Monday, March 25, 2024 at 4:00 p.m. at the company’s registered office, 7 allée Moulin Berger in Ecully (69). Taking into account the representation of defaulting shareholders by SELARL TULIER POLGE ALIREZAI, as ad hoc agent appointed by Order of the President of the Commercial Court of Lyon dated March 7th, 2024, the number of shares held by the shareholders present and represented was of 1 598 755 shares and 100% voting rights. As a quorum was reached, the Meeting was able to be held and make decisions normally. All resolutions submitted to the Combined General Meeting were adopted, with the exception of resolution 22, on the recommendation of the Board of Directors. Information relating to the Combined General Meeting of 25 March 2024 is available on the Company’s website under “Investors/Regulated Information”: https://spineway.com/investors/regulated-information/. SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY SAVINGS PLANS FOR SMES) This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail. Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column. Contacts:
Attachment |
|||||
|
|||||
Copyright 2024 GlobeNewswire | Back to overview list |